Safety and Feasibility of the PEPPER Adaptive Bolus Advisor and Safety System: A Randomized Control Study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: The Patient Empowerment through Predictive Personalized Decision Support (PEPPER) system provides personalized bolus advice for people with type 1 diabetes. The system incorporates an adaptive insulin recommender system (based on case-based reasoning, an artificial intelligence methodology), coupled with a safety system, which includes predictive glucose alerts and alarms, predictive low-glucose suspend, personalized carbohydrate recommendations, and dynamic bolus insulin constraint. We evaluated the safety and efficacy of the PEPPER system compared to a standard bolus calculator. Methods: This was an open-labeled multicenter randomized controlled crossover study. Following 4-week run-in, participants were randomized to PEPPER/Control or Control/PEPPER in a 1:1 ratio for 12 weeks. Participants then crossed over after a washout period. The primary end-point was percentage time in range (TIR, 3.9–10.0 mmol/L [70–180 mg/dL]). Secondary outcomes included glycemic variability, quality of life, and outcomes on the safety system and insulin recommender. Results: Fifty-four participants on multiple daily injections (MDI) or insulin pump completed the run-in period, making up the intention-to-treat analysis. Median (interquartile range) age was 41.5 (32.3–49.8) years, diabetes duration 21.0 (11.5–26.0) years, and HbA1c 61.0 (58.0–66.1) mmol/mol. No significant difference was observed for percentage TIR between the PEPPER and Control groups (62.5 [52.1–67.8] % vs. 58.4 [49.6–64.3] %, respectively, P = 0.27). For quality of life, participants reported higher perceived hypoglycemia with the PEPPER system despite no objective difference in time spent in hypoglycemia. Conclusions: The PEPPER system was safe, but did not change glycemic outcomes, compared to control. There is wide scope for integrating PEPPER into routine diabetes management for pump and MDI users. Further studies are required to confirm overall effectiveness. Clinical trial registration: ClinicalTrials.gov NCT03849755
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Case-Based Reasoning: Foundational Issues, Methodological Variations, and System Approaches
Aamodt, A., & Plaza, E. (1994) · AI Communications · doi:10.3233/aic-1994-7104 · Cited by 5,624 · cited 2×
“To overcome this limitation, we propose the use of case-based reasoning (CBR), an established artificial intelligence (AI) methodology (9,10).”
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
Reddy, M., Pesl, P., Xenou, M., Toumazou, C., Johnston, D., Georgiou, P., Herrero, P., & Oliver, N. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0413 · Cited by 70
Herrero, P., Pesl, P., Bondia, J., Reddy, M., Oliver, N., Georgiou, P., & Toumazou, C. (2015) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2015.02.003 · Cited by 43
Self-citation
Cited by
Randomized Clinical Trials of Machine Learning Interventions in Health Care: A Systematic Review
Plana, D., Shung, D. L., Grimshaw, A. A., Saraf, A., Sung, J. J. Y., & Kann, B. H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.33946 · Cited by 236
Randomized Controlled Trials of Artificial Intelligence in Clinical Practice: Systematic Review
Lam, T. Y. T., Cheung, M. F. K., Munro, Y. L., Lim, K. M., Shung, D., & Sung, J. J. Y. (2022) · Journal of Medical Internet Research · doi:10.2196/37188 · Cited by 120
“The United Kingdom and Spain Safety and feasibility of the PEPPER adaptive bolus advisor and safety system; a randomized control study Avari et al [33], 2020”
InfluentialArtificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00154-2 · Cited by 106
Martindale, A. P. L., Llewellyn, C. D., de Visser, R. O., Ng, B., Ngai, V., Kale, A. U., di Ruffano, L. F., Golub, R. M., Collins, G. S., Moher, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45355-3 · Cited by 58
Enhancing the Capabilities of Continuous Glucose Monitoring With a Predictive App
Herrero, P., Andorrà, M., Babion, N., Bos, H., Koehler, M., Klopfenstein, Y., Leppäaho, E., Lustenberger, P., Peak, A., Ringemann, C., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241267818 · Cited by 31
Self-citation
Metadata
- Authors
- Avari, P., Leal, Y., Herrero, P., Wos, M., Jugnee, N., Arnoriaga-Rodríguez, M., Thomas, M., Liu, C., Massana, Q., Lopez, B., Nita, L., Martin, C., Fernández-Real, J. M., Oliver, N., Fernández-Balsells, M., & Reddy, M.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2021-03-01
- Volume
- 23
- Issue
- 3
- Pages
- 175-186
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W3092501879
- Cited by
- 37
- References
- 4
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Feasibility of the PEPPER Adaptive Bolus Advisor and Safety System: A Randomized Control Study. https://app.cochat.ai/papers/10.1089/dia.2020.0301
- The paper
- Avari, P., Leal, Y., Herrero, P., Wos, M., Jugnee, N., Arnoriaga-Rodríguez, M., Thomas, M., Liu, C., Massana, Q., Lopez, B., Nita, L., Martin, C., Fernández-Real, J. M., Oliver, N., Fernández-Balsells, M., & Reddy, M. (2021). Safety and Feasibility of the PEPPER Adaptive Bolus Advisor and Safety System: A Randomized Control Study. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2020.0301
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.